Artemis Medicare Services Ltd

With a 50.34% gain over the past year, Artemis Medicare Services Ltd has surged from its 52-week low of Rs 202.85 to a fresh high of Rs 361.5 on 10 Sep 2026, showcasing robust momentum amid a broadly subdued market backdrop.

Extending its recent rally, Artemis Medicare Services Ltd touched a fresh 52-week high of Rs 361.5 on 10 Sep 2026, marking a significant milestone in its price journey amid broad-based strength across multiple timeframes.

Artemis Medicare Services Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating, reflecting evolving market perceptions amid a competitive hospital sector landscape. Despite this, the company’s robust returns and improving mojo grade underscore its growing appeal to investors seeking quality small-cap exposure.

Surging past its previous peak, Artemis Medicare Services Ltd touched a new 52-week high of Rs 351.25 on 09 Sep 2026, marking a significant milestone in its price momentum amid a challenging broader market backdrop.

Extending its impressive rally, Artemis Medicare Services Ltd touched a fresh all-time high of Rs 350 on 09 Sep 2026, outperforming the Sensex which declined by 0.63% on the same day. This milestone caps a remarkable run where the stock has surged over 50% in the past year, significantly outpacing its sector and broader market indices.

Artemis Medicare Services Ltd is rated Buy by MarketsMOJO, with this rating last updated on 08 June 2026. While the rating was set on that date, the analysis below reflects the stock’s current fundamentals, returns, and financial metrics as of 08 September 2026, providing investors with an up-to-date view of the company’s position.

Surging to a new 52-week high of Rs 349.9 on 8 Sep 2026, Artemis Medicare Services Ltd has demonstrated remarkable price momentum, outpacing the broader market and its sector peers despite a subdued Sensex environment.

With a decisive surge to Rs 339.6 on 7 Sep 2026, Artemis Medicare Services Ltd has reached a fresh 52-week high, marking a 49.34% gain over the past year. This milestone comes amid a backdrop of broad technical alignment and sustained price momentum, even as the broader Sensex index has retreated over the last three weeks.

Surging past its previous peak, Artemis Medicare Services Ltd touched a fresh 52-week high of Rs 339.4 on 4 Sep 2026, marking a 48.7% gain over the past year and outpacing the Sensex’s decline of 4.97%. This milestone reflects a powerful alignment of technical indicators and sustained price momentum that has propelled the stock well above its key moving averages.

With a decisive surge to Rs 334.8 on 1 Sep 2026, Artemis Medicare Services Ltd has reached a fresh 52-week high, marking a 65.2% rally from its low of Rs 202.85 over the past year. This milestone is underpinned by a strong alignment of technical indicators and sustained price momentum, setting the stock apart in a market where the broader Sensex has struggled to maintain gains.

Artemis Medicare Services Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the company’s current position as of 26 August 2026, providing investors with an up-to-date analysis of the stock’s performance and outlook.

Surging past its previous peak, Artemis Medicare Services Ltd touched a new 52-week high of Rs 332.5 on 21 Aug 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of sustained technical strength and a market environment where the S&P BSE SmallCap Select Index also reached fresh highs.

With a decisive surge to Rs 326 on 20 Aug 2026, Artemis Medicare Services Ltd has reached a fresh 52-week high, marking a 35.43% gain over the past year and outpacing the Sensex’s decline of 5.27%. This milestone reflects a confluence of strong technical momentum and sustained operational performance.

Artemis Medicare Services Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 August 2026, providing investors with the latest insights into its performance and outlook.

With a decisive surge to Rs 325.35 on 10 Aug 2026, Artemis Medicare Services Ltd has reached a fresh 52-week high, marking a 34.58% gain over the past year and outpacing the Sensex’s decline of 1.58%. This milestone reflects a strong alignment of technical indicators and sustained price momentum that has propelled the stock well above its key moving averages.

The Sensex edged up 0.37% on 5 Aug 2026, while Artemis Medicare Services Ltd surged 7.14%, touching an intraday high of Rs 323. This 7.49-percentage-point outperformance over its Hospital sector peers highlights a distinctly stock-specific rally rather than a broad market lift.

Surging to an intraday peak of Rs 312 on 5 Aug 2026, Artemis Medicare Services Ltd has marked a fresh 52-week high, extending its impressive 23.74% return over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades near its own recent peaks.